Highly Prescribed Drug Gets FDA Green Light Despite 4-Fold Higher Risk of Death

Contact Your Elected Officials
The Epoch Times Header

The FDA approved a drug already used in nursing homes, but experts are concerned about its potentially lethal effects.

A questionable green light from the U.S. Food and Drug Administration (FDA). An unproven drug frequently used in nursing homes. Medical experts left confused and concerned.

This is the story surrounding brexpiprazole, branded as Rexulti: the first antipsychotic approved to treat agitation in Alzheimer’s patients despite alarmingly high death rates and poor results in clinical trials.

Patients prescribed brexpiprazole faced a fourfold increased risk of dying compared toย people who didnโ€™t take the drug, according to an investigation published in theย British Medical Journalย (BMJ).

For medical professionals, the FDA’s move raises troubling questions about efficacy, safety, and regulatory diligence.

Watchdog Group Flags Dangers as FDA OKs Alzheimerโ€™s Drug

In an open letter (pdf) from May 3, Nina Zeldes, who has a doctorate in medical anthropology and is a drug safety advocate and researcher for Public Citizen, a consumer advocacy organization, urged the FDA to reject the drug manufacturer’s bid. She argued that the drug has no meaningful benefits and increases patients’ risk of harm.

Approving ineffective drugs erodes public trust and gives false hope to families of Alzheimerโ€™s patients, Ms. Zeldes wrote. Patients need to trust that FDA-approved drugs are safe and effective, she added.

Ms. Zeldes also noted that up to 21 percent of nursing home residents already receive risky antipsychotics, citing a New York Times investigation. According to Ms. Zeldes, approving brexpiprazole could increase the use of these potentially deadly drugs.

However, one week later, on May 11, the FDA approved brexpiprazole to treat agitation in Alzheimerโ€™s patients, citing clinical trials showing โ€œstatistically significant and clinically meaningful improvements.โ€

What Did the Clinical Trials Really Show?

The efficacy of drugs for treating Alzheimer’s dementia is based on a scale called the Cohen-Mansfield Agitation Inventory (CMAI) (pdf) that measures 29 behaviors. Caregivers assign a score of 1 to 7 for each statement for a total score of 29 to 203. Some behaviors listed on the scale include how often a patient:

  • Hits, kicks, and screams.
  • Is restless or paces aimlessly.
  • Screams or curses.
  • Repeatedly asks the same question.
  • Complains or is excessively negative.

To determine effectiveness, a patientโ€™s score must change by a value of 17 after 12 weeks of an intervention to be of clinical value. However, the brexpiprazole trials showed only a 5.3-point maximum reduction in CMAI scores, according to the open letterโ€”far below the efficacy threshold.

Brexpiprazole also increased mortality risk. Over 16 weeks, death rates were four times higher among those prescribed the drug versus placebo. 

Furthermore, common adverse side effects include urinary tract infection, sleepiness, insomnia, and higher incidences of cardiovascular events, Ms. Zeldes added.

Byย Mary Gillis

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

AI is Now an Existential Threat

We now see evidence that artificial intelligence is an existential threat to our future. It is coming to take American jobs!

With or without

The mullahs of Iran have been at war with the West, particularly the US, for half a century and Iran is also the worldโ€™s foremost champion of terrorism.

Artificial Intelligence Equals Awful Iniquities

WSJ article โ€œAI is Learning to Escape Human Controlโ€ said in 79 of 100 trials, the o3 AI code systems edited their own code to prevent human shutdown!

VIDEO: Deranged Feminist vs. Mating Ducks in Epic Public Meltdown

A middle-aged white lady lib harasses mating ducks to โ€œstop it!โ€ because the rough sex they enjoy appears non-consensual on the part of the female.

RFK Jr. Slashes ALL U.S. Funding For Bill Gatesโ€™ Global โ€˜Vaccine Allianceโ€™

Robert F. Kennedy, Jr. recently pulled all U.S. government funding from Bill Gatesโ€™ Global โ€˜Vaccine Allianceโ€™ GAVI.

Nevada Seen as Case Study in Rapid Urban Sprawl Amid a Water Crisis

Nevadaโ€™s rapidly growing population has reached a critical intersection with the regionโ€™s worsening water crisis, according to experts.

US Streamlines Rule for Fining Illegal Immigrants, Will Issue Nearly $1,000 Daily Fines for Noncompliance

DHS and DOJ announced a new joint federal rule that streamlines the process of issuing fines for illegal immigrants, making it easier and more efficient.

Man Indicted on 12 Hate Crime Charges in Attack on Boulder Demonstration for Israeli Hostages

Boulder, CO man accused of hurling Molotov cocktails at demonstrators supporting Israeli hostages indicted by grand jury on 12 hate crime counts.

Newsom Signs California Budget Aimed at Addressing $12 Billion Deficit

Gov. Gavin Newsom signed California budget projected to close a $12 billion deficit through spending reductions on some of the stateโ€™s ongoing programs.

Termination of โ€˜Wasteful Contractsโ€™ Saves US Government $470 Million Last Week: DOGE

Over the past seven days, various government agencies have terminated 312 โ€œwasteful contractsโ€ with a ceiling value of $2.8 billion, the DOGE said.

Trump Says He Will Only Appoint Fed Chair Who Wants to Cut Interest Rates

President Trump said he may appoint someone who is more inclined to lower interest rates to succeed Federal Reserve Chair Jerome Powell.

Trump Says US Ending All Trade Talks With Canada

Trump posted he is ending โ€œallโ€ trade negotiations with Canada due to their plan to impose a digital services tax which affects U.S. tech companies.

White House Confirms US, China Have Reached Additional Trade Agreement

A White House official said the United States and China have reached an additional agreement as trade talks between the two nations continue.
spot_img

Related Articles